ARGININE VASOPRESSIN V1A AND V2 RECEPTORS FOR SECONDARY BRAIN DAMAGE AFTER EXPERIMENTAL TRAUMATIC BRAIN INJURY

被引：0
|
作者：
Sandro, Krieg [1 ]
Trabold [1 ]
Sonanini [1 ]
Plesnila [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany
来源：
JOURNAL OF NEUROTRAUMA | 2011年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [21] Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors
    Rodrigo, Jordi
    Pena, Ana
    Murat, Brigitte
    Trueba, Miguel
    Durroux, Thierry
    Guillon, Gilles
    Rognan, Didier
    MOLECULAR ENDOCRINOLOGY, 2007, 21 (02) : 512 - 523
  • [22] TRAUMATIC BRAIN INJURY RESULTS IN A CONCOMITANT INCREASE IN NEOCORTICAL EXPRESSION OF VASOPRESSIN AND ITS V1A RECEPTOR
    Pascale, C. L.
    Szmydynger-Chodobska, J.
    Sarri, J. E.
    Chodobski, A.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2006, 57 : 161 - 167
  • [23] Conivaptan:: A dual receptor vasopressin V1a/V2 antagonist
    Ali, Farhan
    Raufi, M. Adnan
    Washington, Barbara
    Ghali, Jalal K.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 261 - 279
  • [24] Expression of mRNA encoding vasopressin V1a, vasopressin V2, and ANP-B receptors in the rat cochlea
    Furuta, H
    Luo, L
    Ryan, AF
    Mori, N
    HEARING RESEARCH, 1998, 117 (1-2) : 140 - 148
  • [25] Role of vasopressin V1 receptors for post-traumatic brain edema formation, cerebral blood flow, and secondary brain damage
    Trabold, R.
    Krieg, S.
    Nikolaus, P.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S205 - S205
  • [26] GLIBENCLAMIDE REDUCES SECONDARY BRAIN DAMAGE AFTER EXPERIMENTAL TRAUMATIC BRAIN INJURY
    Zweckberger, K.
    Hackenberg, K.
    Jung, C. S.
    Hertle, D. N.
    Kiening, K. L.
    Unterberg, A. W.
    Sakowitz, O. W.
    NEUROSCIENCE, 2014, 272 : 199 - 206
  • [27] Vasopressin receptors V1(a) and V2 are not osmosensors
    Lykke, Kasper
    Assentoft, Mette
    Fenton, Robert A.
    Rosenkilde, Mette M.
    MacAulay, Nanna
    PHYSIOLOGICAL REPORTS, 2015, 3 (08):
  • [28] Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis
    Terrillon, S
    Durroux, T
    Mouillac, B
    Breit, A
    Ayoub, MA
    Taulan, M
    Jockers, R
    Barberis, C
    Bouvier, M
    MOLECULAR ENDOCRINOLOGY, 2003, 17 (04) : 677 - 691
  • [29] Differentiation of Arginine Vasopressin Antagonistic Effects by Selective V2 versus Dual V2/V1a Receptor Blockade in a Preclinical Heart Failure Model
    Mondritzki, Thomas
    Kolkhof, Peter
    Sabbah, Hani N.
    Gheorghiade, Mihai
    Fuerstner, Chantal
    Schmeck, Carsten
    Siedentop, Harald
    Schaefer, Stefan
    Truebel, Hubert
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (01) : 31 - 37
  • [30] The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease
    Petersen, Mads Bjelke
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (02) : 96 - 103
12345